Indian shares open flat as pharma boost offsets losses in tech stocks

Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks

markets, stock market, sensex, correction, nifty, shares, growth, profit, economy, gain
Reuters BENGALURU
1 min read Last Updated : Jun 28 2021 | 11:25 AM IST

BENGALURU (Reuters) - Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks.

By 0414 GMT, the blue-chip NSE Nifty 50 index was up 0.04% at 15,866.95 and the benchmark S&P BSE Sensex rose 0.02% to 52,936.01.

Both the indexes added more than 1% last week, when the country's vaccinations averaged six million doses per day and some pandemic-induced restrictions were eased further.

On Monday, India reported its lowest increase in COVID-19 deaths since mid-April.

In Mumbai trading, the Nifty Pharma index rose 0.77%, while conglomerate Reliance Industries gained 0.4% after four sessions of losses.

The Nifty IT index fell 0.43% after two straight sessions of gains.

Among global markets, broader Asian shares kicked off the week on a cautious note as a spike in coronavirus cases across the weekend hurt investor sentiment.

 

(Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :share marketTech stocksPharma stocks

First Published: Jun 28 2021 | 11:25 AM IST

Next Story